WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: PARADIGM DX IGG/IGM COVID-19 ANTIBODIES

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on PARADIGM DX IGG/IGM COVID-19 ANTIBODIES

Mark Identification

Proof of use for PARADIGM DX IGG/IGM COVID-19 ANTIBODIES

We do not have any records of a proof of use for PARADIGM DX IGG/IGM COVID-19 ANTIBODIES at this moment.

Click here to add a proof of use for PARADIGM DX IGG/IGM COVID-19 ANTIBODIES

Possible trademark infringements of PARADIGM DX IGG/IGM COVID-19 ANTIBODIES

Basic Information about PARADIGM DX IGG/IGM COVID-19 ANTIBODIES

Serial Number
90028323
Filing Date
30 Jun 2020
Registration Number
6359980
Registration Date
25 May 2021
Mark Drawing Code
3

Classifications

Declare the trademark use of PARADIGM DX IGG/IGM COVID-19 ANTIBODIES on the blockchain with WikiTrademarks.io.

First use of PARADIGM DX IGG/IGM COVID-19 ANTIBODIES anywhere
PARADIGM DX IGG/IGM COVID-19 ANTIBODIES was first used on 11 Jun 2020 for the primary classification of goods and services, international, 042 (Computer, scientific & legal)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
042
US Codes
100; 101

Who owns PARADIGM DX IGG/IGM COVID-19 ANTIBODIES?

Correspondent

MICHAEL E. ROBINSON
ROBINSON IP LAW, PLLC
9724 KINGSTON PIKE, SUITE 1102
KNOXVILLE, TN 37922

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on PARADIGM DX IGG/IGM COVID-19 ANTIBODIES